Markets:

Overview

News

Currencies

International

Treasuries

Tilray Brands, Inc. - Common Stock (NQ:TLRY)

6.890 +0.140 (+2.07%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Tilray Brands, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Marijuana Rescheduling Has Arrived. Don't Make This Mistake ↗

Today 15:20 EDT

The Trump administration recently rescheduled medical marijuana from a Schedule I to Schedule III substance.

Via The Motley Fool

Topics Cannabis Government

This Trump Policy Shift Could Be a Game Changer for Cannabis Stocks: 2 Stocks to Watch Now

Today 10:17 EDT

A federal shift toward Schedule 3 may boost cannabis stocks, even as recreational use remains restricted.

Via Barchart.com

Topics Cannabis Government Law Enforcement

Is Tilray a Textbook Example of a Value Trap? ↗

April 25, 2026

Tilray doesn't fit squarely into the value trap or value stock categories.

Via The Motley Fool

Topics Cannabis

The Cannabis Sector's Billion-Dollar Tax Cut ↗

April 23, 2026

Via MarketBeat

Topics Cannabis

Tilray Stock Jumps As Trump Administration Eyes Marijuana Reclassification: Report ↗

April 22, 2026

Shares of Tilray Brands (NASDAQ: TLRY) are trading higher Wednesday afternoon following breaking news of a potential major regulatory shift.

Via Benzinga

Topics Cannabis Government

1 Wall Street Analyst Says Tilray Stock Could Jump Over 40%. Should You Believe It? ↗

April 22, 2026

Tilray is showing signs of improvement. But a 40% jump over the next 12 months might be a stretch.

Via The Motley Fool

Topics Cannabis

Here's What to Expect From Air Products and Chemicals' Next Earnings Report

April 20, 2026

Air Products and Chemicals is expected to release its fiscal second-quarter earnings this month, and analysts project a double-digit earnings growth.

Via Barchart.com

Topics Cannabis ETFs

Tilray Stock Pops on New Trump-Driven Cannabis Hopes. Should You Chase the Rally?

April 20, 2026

Tilray shares rally as Trump urges the DOJ to quickly reclassify cannabis as a Schedule III drug. Options pricing suggests TLRY stock could rip higher through mid-September.

Via Barchart.com

Topics Cannabis Government

Apple's Q2 2026 Earnings: What to Expect

April 20, 2026

Apple is expected to announce its second-quarter results this month, and analysts are projecting a double-digit rise in its EPS

Via Barchart.com

Topics Cannabis ETFs

The 420 Failure: Here's the Real Reason Tilray Brands Has Been a Horrible Investment Despite Operating in a Legal Marijuana Market ↗

April 20, 2026

The cannabis stock has lost around 96% of its value over the past five years.

Via The Motley Fool

Topics Cannabis

Why Is Tilray Brands Stock Falling Wednesday? ↗

April 15, 2026

Tilray (TLRY) shares dip on a $180M equity program. Explore its global push into U.K. healthcare, BrewDog growth, and U.S. market strategy.

Via Benzinga

Tilray Posted Record Numbers Last Quarter, but Where the Bulk of Its Growth Has Come From Over the Past 4 Years Might Surprise You ↗

April 13, 2026

Tilray has leaned on acquisitions heavily over the past few years in order to grow its business.

Via The Motley Fool

Topics Cannabis

Why Tilray Stock Got Hammered in March ↗

April 08, 2026

What's another month of struggle for a company in the cannabis industry?

Via The Motley Fool

Topics Cannabis

What's Going On With Tilray Brands Stock On Wednesday? ↗

April 08, 2026

Tilray shares gained after launching a high-potency cannabis brand, with innovation and strong momentum outweighing mixed technical signals.

Via Benzinga

Topics Cannabis

Why Tilray Brands Investors Shouldn't Expect the Company to Post a Profit Anytime Soon ↗

April 06, 2026

The company's loss shrank drastically last quarter, but that was largely because it didn't incur significant impairment charges.

Via The Motley Fool

Topics Cannabis

Tilray Brands Reports Record Q3 2026 Results: A Deep Dive into the $207 Million Revenue Milestone

April 06, 2026

Tilray Brands (NASDAQ:TLRY) has officially transitioned from a volatile cannabis producer to a diversified global consumer packaged goods (CPG) powerhouse, reporting record-breaking Q3 fiscal 2026...

Via MarketMinute

Topics Cannabis Earnings Economy

Forget Tilray: This Boring Dividend Beast Is a Much Savvier Play ↗

April 04, 2026

And it's in a cannabis-adjacent sector.

Via The Motley Fool

Topics Cannabis

Tilray Brands Surges on Record $207 Million Q3 Revenue: Margin Recovery in Beverages and German Cannabis Growth Signal Turnaround

April 02, 2026

NEW YORK — Tilray Brands, Inc. (NASDAQ:TLRY) delivered a resounding message to the market this week, reporting a record-breaking $206.7 million in net revenue for its fiscal 2026 third quarter. The...

Via MarketMinute

Topics Cannabis Earnings Economy

Tilray Stock Continues To Climb After Earnings Beat, Record Revenue ↗

April 02, 2026

Tilray Brands shares are trading higher Thursday afternoon after the company's fiscal Q3 results topped Wall Street expectations.

Via Benzinga

Topics Earnings

Tilray Surges on Record Revenue and Global Expansion Despite Third-Quarter Earnings Miss

April 01, 2026

In a paradoxical display of market confidence, shares of Tilray Brands (NASDAQ:TLRY) surged over 8% on Wednesday following the release of its fiscal third-quarter 2026 financial results. While the...

Via MarketMinute

Topics Cannabis Earnings

Tilray Brands Reaffirms Outlook After Record Quarter ↗

April 01, 2026

Tilray (TLRY) shares jump in premarket after record Q3 results. Adjusted EPS of $0.02 beats estimates as revenue hits a record $206.7M.

Via Benzinga

Why Tilray Brands Shares Are Surging In Wednesday's Premarket ↗

April 01, 2026

Tilray Brands Inc (TLRY) shares are climbing in Wednesday's premarket as the company prepares to report Q3 fiscal 2026 results.

Via Benzinga

Tilray's Shock Top Unveils Its Strongest Beer Ever ↗

March 31, 2026

TLRY premarket gains follow Shock Top's first high-ABV beer launch. See how Tilray Brands is innovating in the craft beverage segment.

Via Benzinga

What's Going On With Tilray Brands Stock? ↗

March 19, 2026

Tilray expanded its medical cannabis portfolio in Australia, but market weakness overshadows the company's push into a key growth market.

Via Benzinga

Topics Cannabis

Why I Wouldn't Touch Tilray Brands Stock With a 10-Foot Pole ↗

March 18, 2026

The stock has been a wealth destroyer for a while.

Via The Motley Fool

Topics Cannabis

Will Tilray Brands' Diversification Strategy Pay Off for Investors? ↗

March 16, 2026

Tilray Brands' business has become larger over the years as it has expanded into beverages.

Via The Motley Fool

Topics Cannabis

Tilray Expands German Healthcare Push With Strategic Pharma Deal ↗

March 12, 2026

Tilray slipped Thursday despite expanding its Germany healthcare partnership, as investors weighed the strategic move against broader market weakness and company-specific pressure.

Via Benzinga

Tilray Taps Light Beer Market With New 'Pub Light' Launch ↗

March 11, 2026

Tilray (TLRY) shares rise premarket as the company launches Pub Light beer and expands its global beverage portfolio. Get the latest details.

Via Benzinga

Tilray's BrewDog Australia Deal Opens Gateway To Asia-Pacific Expansion ↗

March 09, 2026

Tilray scales its international footprint with BrewDog's Australian operations, targeting new retail markets in Japan and the APAC region.

Via Benzinga

Tilray Brands Expects to Generate $1.2 Billion in Revenue Next Year, and It's Not the Way Investors Might Have Expected ↗

March 09, 2026

Tilray has been loading up on acquisitions over the years, which have expanded and diversified its operations.

Via The Motley Fool

Topics Cannabis

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.